← Back to Search

Connect2Test for Coronavirus Pandemic

N/A
Waitlist Available
Research Sponsored by University of Oregon
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 9-months after intervention
Awards & highlights

Study Summary

This trial will compare the effectiveness of two different approaches to increasing SARS-CoV-2 testing and vaccination uptake among people who inject drugs (PWIDs). The first approach is contingency management (CM), which uses rewards to motivate behavior change. The second approach is CM plus a brief motivational enhancement intervention (MEI). The goal of this trial is to reduce COVID-19 health disparities among PWIDs and to decrease population level COVID-19 morbidity and mortality.

Eligible Conditions
  • Coronavirus Pandemic

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 9-months after intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 9-months after intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
SARS-CoV-2 Testing
Secondary outcome measures
Vaccination

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Connect2Test Intervention + Contingency ManagementExperimental Treatment1 Intervention
$10 financial incentive for vaccination and $10 financial incentive for testing plus a brief feedback-based motivational enhancement intervention.
Group II: Contingency Management AloneActive Control1 Intervention
$10 financial incentive for vaccination and $10 financial incentive for testing.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Connect2Test
2022
N/A
~350

Find a Location

Who is running the clinical trial?

University of OregonLead Sponsor
80 Previous Clinical Trials
46,553 Total Patients Enrolled
National Institute on Drug Abuse (NIDA)NIH
2,485 Previous Clinical Trials
2,622,031 Total Patients Enrolled
~127 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top